Metacrine, Inc. (NASDAQ:MTCR) Sees Large Decline in Short In

Metacrine, Inc. (NASDAQ:MTCR – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 808,600 shares, a drop of 33.7% from the April 15th total of 1,220,000 shares. Based on an average trading volume of 1,730,000 shares, the short-interest […]

Related Keywords

United States , America , , York Mellon Corp , Goldman Sachs Group Inc , Zacks Investment Research , Renaissance Technologies , Metacrine Inc , America Corp , Nasdaq , Get Rating , New York Mellon Corp , Sachs Group , Metacrine , Nasdaq Mtcr , Mtcr , Medical , Stocks , Options , Put , Call ,